NCT00238745View on ClinicalTrials.gov

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

PHASE2CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

March 31, 2007

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

Bazedoxifene

DRUG

Placebo

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00238745 - Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. | Biotech Hunter | Biotech Hunter